Innate Immunity

In cancer research, the role of innate immunity is gaining significant attention due to its intricate relationship with tumor development and progression. Innate immunity serves as the body's first line of defense against foreign invaders, including cancer cells. Natural killer (NK) cells, macrophages, and dendritic cells are key players in innate immunity, recognizing and eliminating aberrant cells. However, cancer cells often evade this surveillance by exploiting immune checkpoint pathways or by creating an immunosuppressive microenvironment. Understanding the interplay between innate immunity and cancer is crucial for developing novel immunotherapeutic strategies that harness the power of the immune system to target and eradicate tumors effectively. Harnessing the innate immune response holds promise for advancing cancer treatment, offering new avenues for personalized and targeted therapies.